Croda International (LON:CRDA – Get Free Report) posted its quarterly earnings results on Tuesday. The company reported GBX 146.20 earnings per share (EPS) for the quarter, Digital Look Earnings reports. Croda International had a return on equity of 6.96% and a net margin of 9.98%.
Here are the key takeaways from Croda International’s conference call:
- FY2025 underlying results showed improvement with sales +7% (cc) to £1.7bn, adjusted operating profit +8% to £295m, adjusted PBT +8% to £276m, free cash flow £162m and net debt reduced to £524m (1.3x EBITDA).
- The company is executing a transformation program targeting £100m of annualized savings and £50m working capital reduction by 2028, and is guiding to >20% adjusted operating margin, >12% free cash flow-to-sales and >10% ROIC by 2028.
- Reported profit before tax was materially below adjusted PBT—£91m vs £276m—after £150m of exceptional charges
- Portfolio and demand trends underpin growth: sales of patented ingredients rose 9%, Flavours & Fragrances grew ~15%, Crop Protection +14%, and the business mix now has 89% exposure to Consumer/Pharma/Agriculture and 48% of sales outside Europe/North America.
- Near-term guidance: management expects organic group growth of ~3–6% (with Consumer 3–6% and Life Sciences 4–7%), Q1 sales broadly flat vs a strong Q1-2025, and adjusted operating profit in line with market expectations.
Croda International Price Performance
Shares of CRDA stock opened at GBX 3,195 on Thursday. The business’s fifty day moving average is GBX 2,827.53 and its 200 day moving average is GBX 2,741.12. The company has a quick ratio of 2.25, a current ratio of 2.72 and a debt-to-equity ratio of 30.90. The stock has a market cap of £4.46 billion, a price-to-earnings ratio of 20.75, a PEG ratio of 1.40 and a beta of 0.74. Croda International has a twelve month low of GBX 2,426.77 and a twelve month high of GBX 3,336.
Analyst Upgrades and Downgrades
Get Our Latest Stock Report on CRDA
Croda International Company Profile
Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.
See Also
- Five stocks we like better than Croda International
- REVEALED: Something Big Happening Behind White House Doors
- MAJOR BUY ALERT: Mar-a-Lago/Trump/Elon
- ALERT: Drop these 5 stocks before the market opens tomorrow!
- Why the Smart Money Is Looking Beyond Single-Metal Stories
- Read this or regret it forever
Receive News & Ratings for Croda International Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Croda International and related companies with MarketBeat.com's FREE daily email newsletter.
